BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 29, 2014
View Archived Issues
The effect of bisphosphonate compounds in animal models of acute colitis
Read More
Recessive variant found in PCD deficiency with MODY-like diabetes
Read More
Invion updates on ongoing phase II trial of nadolol in mild asthma
Read More
Eutropics receives NCI contract to develop predictive tests for personalized AML treatment
Read More
Lipocine reports topline results from phase III trial of LPCN-1021
Read More
BerGenBio granted Wellcome Trust award for cancer development program
Read More
AstraZeneca discloses new FGFR-4 inhibitors
Read More
Reduced HYAL2 gene methylation in blood correlated with breast cancer
Read More
Safety and pharmacokinetics of ABT-767 in BRCA1 and BRCA2 germline tumors
Read More
FDA approves Vitekta
Read More
CHMP recommends approval of aclidinium bromide/formoterol fumarate
Read More
EMA recommends ketoconazole for approval in Cushing's syndrome
Read More
EMA committee recommends approval of Moventig
Read More
Roche divulges novel CB2 receptor agonists
Read More
Allergan discloses novel S1P1 receptor ligands
Read More
Roche discloses new agents for HCV infection
Read More
Genzyme presents promising data from 3-year follow up of CARE-MS I
Read More
New LRRK2 inhibitors disclosed by Merck & Co.
Read More
Application filed for marketing approval of remestemcel-L in Japan
Read More
Novartis applies for Japanese approval of panobinostat
Read More
EMA committee hands down positive opinion on Trulicity
Read More
FDA approves Iluvien for diabetic macular edema
Read More
Harvoni recommended for the treatment of chronic hepatitis C
Read More
EMA committee recommends European approval of Cyramza
Read More
Lixiana approved in Japan for additional indications
Read More
Signifor recommended by CHMP to treat patients with acromegaly
Read More
Boehringer Ingelheim's nintedanib receives positive opinion for second-line therapy of NSCLC
Read More